Liesl M. Hagan

Liesl M. Hagan

Auto-generated profile, based on publicly available information

Liesl M. Hagan

Office of Readiness and Response, Centers for Disease Control and Prevention, Atlanta, GA, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2020 in MMWR. Morbidity and Mortality Weekly Report
Verified
Journal Article
Closed access
LHLiesl M Hagan
Liesl M Hagan
SWSamantha P Williams
Samantha P Williams
ASAnne C Spaulding
Anne C Spaulding
RTRobin L Toblin
Robin L Toblin
JFJessica Figlenski
Jessica Figlenski
SHSenad Handanagic
Senad Handanagic
This report describes the results of mass COVID-19 testing among incarcerated persons in prisons and jails in 16 adult correctional and detention facilities in the United States.

24 September 2021 in MMWR. Morbidity and Mortality Weekly Report
Verified
Journal Article
Open access
LHLiesl M. Hagan
Liesl M. Hagan
DMDavid W. McCormick
David W. McCormick
CLChristine Lee
Christine Lee
SSSadia Sleweon
Sadia Sleweon
LNLavinia Nicolae
Lavinia Nicolae
JTJacqueline E. Tate
Jacqueline E. Tate
This report describes an outbreak with the Delta variant in a federal Texas prison among unvaccinated and vaccinated persons.

10 May 2019 in BMC Public Health
Verified
Journal Article
Open access
PDF file
LHLiesl M. Hagan
Liesl M. Hagan
AKAna Kasradze
Ana Kasradze
SSStephanie Salyer
Stephanie Salyer
AGAmiran Gamkrelidze
Amiran Gamkrelidze
MAMaia Alkhazashvili
Maia Alkhazashvili
FAFrancisco Averhoff
Francisco Averhoff
The country of Georgia launched the world’s first Hepatitis C Virus (HCV) Elimination Program in 2015 and set a 90% prevalence reduction goal for 2020. We conducted a nationally representative HCV seroprevalence survey to establish baseline prevalence to measure progress toward elimination over time. A cross-sectional seroprevalence survey was conducted in 2015 among adults aged ≥18 years using a stratified, multi-stage cluster design (n = 7000). Questionnaire variables included demographic, medical, and behavioral risk characteristics and HCV-related knowledge. Blood specimens were tested for antibodies to HCV (anti-HCV) and HCV RNA. Frequencies were computed for HCV prevalence, risk factors, and HCV-related knowledge. Associations between anti-HCV status and potential risk factors were calculated using logistic regression. National anti-HCV seroprevalence in Georgia was 7.7% (95% confidence interval (CI) = 6.7, 8.9); HCV RNA prevalence was 5.4% (95% CI = 4.6, 6.4). Testing anti-HCV+ was significantly associated with male sex, unemployment, urban residence, history of injection drug use (IDU), incarceration, blood transfusion, tattoos, frequent dental cleanings, medical injections, dialysis, and multiple lifetime sexual partners. History of IDU (adjusted odds ratio (AOR) = 21.4, 95% CI = 12.3, 37.4) and blood transfusion (AOR = 4.5, 95% CI = 2.8, 7.2) were independently, significantly associated with testing anti-HCV+ after controlling for sex, age, urban vs. rural residence, and history of incarceration. Among anti-HCV+ participants, 64.0% were unaware of their HCV status, and 46.7% did not report IDU or blood transfusion as a risk factor. Georgia has a high HCV burden, and a majority of infected persons are unaware of their status. Ensuring a safe blood supply, implementing innovative screening strategies beyond a risk-based approach, and intensifying prevention efforts among persons who inject drugs are necessary steps to reach Georgia’s HCV elimination goal.

1 September 2021 in Vaccine
Verified
Journal Article
Closed access
LHLiesl M. Hagan
Liesl M. Hagan
CDCharles Dusseau
Charles Dusseau
MCMichael Crockett
Michael Crockett
TRTami Rodriguez
Tami Rodriguez
MLMichael J. Long
Michael J. Long

10 May 2019 in BMC Public Health
Verified
Journal Article
Open access
PDF file
SRSteven Russell
Steven Russell
LSLela Sturua
Lela Sturua
CLChaoyang Li
Chaoyang Li
JMJuliette Morgan
Juliette Morgan
MTMarina Topuridze
Marina Topuridze
SSStephanie Salyer
Stephanie Salyer
Non-communicable diseases (NCDs), mainly cardiovascular diseases, are a substantial cause of mortality in the country of Georgia, accounting for approximately 93% of all deaths (standardized mortality rate 630.7 deaths per 100,000 persons per year) and an important threat to health security. We conducted a nationally representative survey examining the prevalence of NCDs and their risk factors as part of a 2015 Hepatitis C Virus (HCV) and Hepatitis B Virus (HBV) serosurvey. We conducted a cross-sectional serosurvey among adults aged ≥18 years using a stratified, multi-stage cluster design (n = 7000). We asked participants standardized questions from the Global Adult Tobacco Survey and the WHO STEPwise approach to Surveillance (STEPS) Survey. We also measured blood pressure and Body Mass Index for each participant. Weighted frequencies were computed for NCD and risk factor prevalence and compared to 2010 STEPS results. Georgians reported high rates of smoking, alcohol use, elevated blood pressure, obesity, diabetes and cardiovascular disease. An estimated 27.1% (95% confidence interval [CI]: 25.3, 28.8%) of adults (51.5% of men and 6.0% of women) reported daily use of tobacco products and 27.5% (95% CI: 25.7, 29.2%) of adults (52.1% of men and 7.0% of women) reported binge drinking within the last 30 days. Physical measurements revealed that 37.5% (95% CI: 35.8, 39.3%) of adults had elevated blood pressure and 33.4% (95% CI: 31.8, 35.0%) had obesity. 5.4% (95% CI: 4.6, 6.2%) of adults had self-reported diagnosed diabetes and 15.3% (95% CI: 14.1, 16.6%) had self-reported diagnosed cardiovascular disease. From 2010 to 2015, the prevalence of obesity increased by 8.3 percentage points (95% CI: 5.9, 10.7%; p < 0.01) and the prevalence of elevated blood pressure increased by 4.1 percentage points (95% CI: 1.4, 6.8%; p < 0.01). Georgia has a high NCD burden, and results from the survey showed an increase in obesity and elevated blood pressure since 2010. The prevalence of other major NCDs have remained near levels reported in the 2010 STEPs survey. Comprehensive public health interventions are needed to control the heath security threats of major NCDs and their risk factors in the future.

7 October 2022 in MMWR. Morbidity and Mortality Weekly Report
Verified
Journal Article
Open access
LHLiesl M. Hagan
Liesl M. Hagan
This report describes an analysis of monkeypox transmission risk among residents of Cook County Jail, Chicago, Illinois, who had been housed with a resident with symptomatic monkeypox.